NCT03426904View on ClinicalTrials.gov

Neoadjuvant FOLFOX Chemotherapy for Patients With Locally Advanced Colon Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

708

Participants

Timeline

Start Date

October 24, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 28, 2030

Conditions
Colon Cancer
Interventions
DRUG

Neoadjuvant FOLFOX

4 cycles of FOLFOX neoadjuvant chemotherapy and 8 cycles of postoperative chemotherapy

DRUG

Conventional adjuvant FOLFOX

12 cycles of postoperative FOLFOX chemotherapy

Trial Locations (4)

41404

Kyungpook National University Chilgok Hospital, Daegu

58128

Chonnam National University Hwasun Hospital, Hwasun

05505

Asan Medical Center, Seoul

Unknown

The Catholic Univ. of Korea St. Vincent's Hospital, Suwon

All Listed Sponsors
lead

Kyungpook National University Hospital

OTHER